
Sima Lev: Oligomerization and conformational changes within the MSP are required for VAP-B(P56S) aggregation and neurotoxicity
Oligomerization and conformational changes within the MSP are required for VAP-B(P56S) aggregation and neurotoxicity
Membrane Trafficking | Health & Disease

Oligomerization and conformational changes within the MSP are required for VAP-B(P56S) aggregation and neurotoxicity